Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Last Close
24.42
Aug 24 • 3:59 PM ET Dollar change+0.45 Percentage change(1.88%)
Aftermarket Close
24.42
Aftermarket • 7:51 PM ET Dollar change+0.00 Percentage change(0.02%)
Index
-
Market Cap
12.20B
Enterprise Value
15.59B
Income
-199.00M
Sales
5.02B
Book/sh
13.19
Cash/sh
1.06
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
9900
IPO
Sep 20, 2018
P/E
-
Forward P/E
19.19
PEG
1.23
P/S
2.43
P/B
1.85
P/C
23.02
P/FCF
32.19
EV/EBITDA
15.19
EV/Sales
3.11
Quick Ratio
1.10
Current Ratio
2.05
Debt/Eq
0.59
LT Debt/Eq
0.58
Option/Short
Yes / Yes
EPS (ttm)
-0.40
EPS next Y
1.27
EPS next Q
0.21
EPS this Y
20.62%
EPS next Y
12.25%
EPS next 5Y
15.54%
EPS past 3/5Y
-43.04% 18.11%
Sales past 3/5Y
2.25% 7.57%
EPS Y/Y TTM
-145.71%
Sales Y/Y TTM
11.95%
EPS Q/Q
380.63%
Sales Q/Q
10.23%
Insider Own
1.01%
Insider Trans
1.47%
Inst Own
113.82%
Inst Trans
4.23%
ROA
-1.46%
ROE
-2.98%
ROIC
-1.91%
Gross Margin
44.28%
Oper. Margin
6.63%
Profit Margin
-3.96%
SMA20
0.57%
SMA50
-0.51%
SMA200
3.40%
Trades
Shs Outstand
499.55M
Shs Float
494.59M
52W High
27.98 -12.72%
52W Low
17.11 42.72%
Volatility
2.49% 4.12%
ATR (14)
1.00
RSI (14)
51.67
Beta
1.68
Rel Volume
0.63
Avg Volume
6.31M
Volume
3,952,274
Perf Week
3.43%
Perf Month
-1.97%
Perf Quarter
12.38%
Perf Half Y
-1.33%
Perf YTD
7.91%
Perf Year
36.35%
Perf 3Y
109.25%
Perf 5Y
-24.35%
Perf 10Y
-
Prev Close
23.97
Price
24.42
Change %
1.88%
Date Action Analyst Rating Change Price Target Change
Apr-15-26Initiated Citigroup Buy $30
Jan-22-26Upgrade Piper Sandler Neutral → Overweight
Dec-09-25Initiated Barclays Overweight $30
Nov-21-25Initiated KeyBanc Capital Markets Overweight $27
Nov-19-25Upgrade Argus Hold → Buy $25
Oct-07-25Upgrade JP Morgan Neutral → Overweight $24
Jul-17-25Upgrade Leerink Partners Market Perform → Outperform $18
Jun-26-25Upgrade William Blair Mkt Perform → Outperform
Dec-09-24Initiated UBS Buy $18
Dec-02-24Initiated Leerink Partners Market Perform $14
Aug-07-26 02:20PM
Aug-06-26 05:33PM
Aug-05-26 03:01PM
06:27AM
Jul-31-26 07:32AM
06:27AM Loading…
Jul-22-26 06:27AM
Jul-08-26 08:00AM
Jun-18-26 07:26AM
Jun-15-26 08:47AM
Jun-04-26 01:47PM
10:23AM
06:26AM
Jun-03-26 07:26AM
May-18-26 07:27AM
May-14-26 08:00AM
12:51PM Loading…
May-06-26 12:51PM
08:12AM
06:27AM
Apr-27-26 06:23PM
Apr-16-26 08:00AM
Apr-15-26 09:47AM
Apr-13-26 04:08PM
Apr-09-26 08:27AM
Mar-23-26 01:38PM
Mar-16-26 03:23PM
Feb-26-26 09:56AM
Feb-24-26 04:22PM
03:08PM
02:01PM
12:32PM
11:25AM Loading…
11:25AM
09:30AM
08:15AM
06:38AM
06:27AM
Feb-23-26 10:57AM
Feb-22-26 10:06PM
Feb-19-26 09:15AM
08:00AM
Feb-13-26 09:24AM
Feb-10-26 06:41AM
Jan-30-26 11:56AM
Jan-28-26 07:50AM
Jan-27-26 04:04PM
Jan-26-26 11:35PM
Jan-22-26 04:36PM
08:00AM
06:00AM
Jan-12-26 06:54PM
Jan-06-26 11:08PM
06:52PM
08:00AM
Dec-31-25 02:00PM
Dec-21-25 10:07AM
Dec-19-25 01:30AM
Dec-18-25 08:43AM
Dec-16-25 02:05PM
09:40AM
Dec-12-25 12:00PM
Dec-09-25 04:15PM
07:40AM
Nov-24-25 07:00PM
Nov-21-25 01:35PM
Nov-20-25 08:00AM
Nov-14-25 09:03AM
Nov-13-25 08:00AM
Nov-12-25 12:35AM
Nov-11-25 08:46AM
Nov-06-25 12:33AM
Nov-05-25 07:26PM
03:12PM
02:01PM
09:30AM
07:35AM
06:36AM
06:27AM
Nov-03-25 10:19PM
04:28PM
Oct-29-25 10:00AM
Oct-28-25 11:27AM
Oct-27-25 06:27AM
Oct-24-25 05:33PM
04:55PM
12:02AM
Oct-23-25 11:40AM
Oct-22-25 09:40AM
Oct-20-25 02:03PM
Oct-17-25 06:39PM
Oct-16-25 04:32PM
Oct-08-25 12:00PM
Oct-07-25 11:31AM
Oct-06-25 11:40AM
05:15AM
Oct-01-25 08:00AM
Sep-30-25 12:00PM
Sep-24-25 12:01PM
Sep-23-25 07:10PM
06:27AM
Sep-11-25 10:57PM
Sep-08-25 03:35PM
Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. The company was founded in 1954 and is headquartered in Indianapolis, IN.
PresidentMr. Jeffrey N. Simmons
Executive VP & CFOMr. Robert M. VanHimbergen
Executive VP & President of Elanco InternationalDr. Ramiro Martin Cabral
Executive Vice President of ResearchDr. Ellen de Brabander Ph.D.
Executive Vice President of Center of Strategic GrowthMr. Timothy J. Bettington
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kurzius Lawrence ErikDirectorAug 20 '26Buy23.4040,000935,920188,647Aug 21 04:16 PM
O'Neill ShivGC AND CORP SECAug 18 '26Buy23.583,99894,27387,832Aug 18 04:32 PM
Harrington Michael JDirectorAug 12 '26Buy21.825,000109,100131,451Aug 13 04:28 PM
VanHimbergen Robert MEVP and CFOAug 07 '26Buy23.084,20096,926137,516Aug 10 04:14 PM
Herendeen PaulDirectorAug 07 '26Buy23.6810,000236,850111,687Aug 10 04:13 PM
Modi Rajeev A.SEE REMARKSMay 15 '26Buy20.354,91199,939160,812May 19 04:39 PM
Simmons Jeffrey NPRESIDENT, CEO AND DIRECTORMay 15 '26Buy20.094,97199,843171,971May 19 04:38 PM
Kurzius Lawrence ErikDirectorDec 12 '25Buy21.3010,000213,000131,773Dec 16 04:42 PM
Modi Rajeev A.SEE REMARKSDec 11 '25Buy21.334,50095,985123,082Dec 15 04:43 PM
VanHimbergen Robert MEVP and CFODec 11 '25Buy21.646,950150,426124,233Dec 15 04:42 PM
Simmons Jeffrey NPRESIDENT, CEO AND DIRECTORDec 11 '25Buy21.7522,000478,496167,000Dec 15 04:41 PM
Last Close
56.20
Aug 24 • 3:59 PM ET Dollar change+0.79 Percentage change(1.43%)
Aftermarket Close
56.11
Aftermarket • 7:30 PM ET Dollar change-0.09 Percentage change(-0.16%)
MKC McCormick & Co Inc daily Stock Chart
Index
S&P 500
Market Cap
15.11B
Enterprise Value
20.29B
Income
1.62B
Sales
7.39B
Book/sh
26.02
Cash/sh
1.23
Employees
14100
IPO
Mar 17, 1980
P/E
9.35
Forward P/E
17.06
PEG
2.57
P/S
2.05
P/B
2.16
P/C
45.63
P/FCF
14.82
EV/EBITDA
13.60
EV/Sales
2.75
Quick Ratio
0.39
Current Ratio
0.78
Debt/Eq
0.71
LT Debt/Eq
0.51
Option/Short
Yes / Yes
EPS (ttm)
6.01
EPS next Y
3.29
EPS next Q
0.76
EPS this Y
2.88%
EPS next Y
6.75%
EPS next 5Y
6.63%
EPS past 3/5Y
5.10% 1.08%
Sales past 3/5Y
2.51% 4.08%
EPS Y/Y TTM
108.44%
Sales Y/Y TTM
9.54%
EPS Q/Q
-14.16%
Sales Q/Q
16.70%
Insider Own
6.24%
Insider Trans
-1.19%
Inst Own
91.59%
Inst Trans
8.22%
ROA
10.91%
ROE
25.70%
ROIC
15.28%
Gross Margin
38.92%
Oper. Margin
16.72%
Profit Margin
21.91%
SMA20
5.30%
SMA50
8.81%
SMA200
-2.45%
Trades
Shs Outstand
254.06M
Shs Float
253.75M
52W High
72.58 -22.57%
52W Low
44.82 25.39%
Volatility
2.69% 2.62%
ATR (14)
1.52
RSI (14)
65.01
Beta
0.64
Rel Volume
0.49
Avg Volume
3.96M
Volume
1,922,627
Perf Week
4.19%
Perf Month
12.49%
Perf Quarter
17.57%
Perf Half Y
-19.17%
Perf YTD
-17.49%
Perf Year
-22.23%
Perf 3Y
-30.61%
Perf 5Y
-34.56%
Perf 10Y
10.59%
Prev Close
55.41
Price
56.20
Change %
1.43%
Date Action Analyst Rating Change Price Target Change
Apr-14-26Initiated BTIG Research Neutral
Dec-15-25Upgrade Deutsche Bank Hold → Buy $75
Aug-20-25Upgrade JP Morgan Neutral → Overweight $83
Jun-16-25Initiated UBS Neutral $83
Mar-27-25Downgrade Argus Buy → Hold
Jan-08-25Upgrade TD Cowen Hold → Buy $86 → $90
Dec-09-24Upgrade Jefferies Hold → Buy $85 → $91
Jun-12-24Upgrade Citigroup Sell → Neutral $68 → $69
Apr-02-24Upgrade Argus Hold → Buy
Feb-01-24Initiated Citigroup Sell $60
Aug-20-26 08:00AM
Aug-07-26 05:42AM
Jul-31-26 05:00AM
Jul-30-26 02:48PM
Jul-27-26 04:01AM
02:47PM Loading…
Jul-23-26 02:47PM
07:18AM
06:00AM
Jul-02-26 09:58AM
Jun-25-26 03:00PM
11:00AM
10:12AM
08:29AM
07:16AM
07:08AM
06:36AM Loading…
06:36AM
06:30AM
04:44AM
Jun-23-26 04:45PM
Jun-05-26 08:44AM
Jun-01-26 08:10AM
May-26-26 04:15PM
May-22-26 09:15AM
12:01AM
May-18-26 08:00AM
May-15-26 05:42PM
May-14-26 04:15PM
May-10-26 11:00AM
May-08-26 05:00AM
Apr-29-26 05:00AM
03:12PM Loading…
Apr-21-26 03:12PM
08:23AM
05:30AM
Apr-17-26 10:00AM
Apr-14-26 04:11PM
09:53AM
Apr-13-26 08:30AM
Apr-09-26 05:07PM
04:29PM
12:37PM
Apr-08-26 04:21PM
Apr-06-26 05:30PM
Apr-02-26 10:30AM
Apr-01-26 09:17AM
08:15AM
Mar-31-26 09:33PM
08:00PM
05:10PM
03:01PM
01:56PM
01:00PM
12:48PM
12:45PM
12:18PM
10:59AM
10:26AM
09:47AM
08:35AM
08:35AM
08:16AM
07:55AM
07:52AM
07:35AM
07:00AM
06:38AM
06:30AM
06:16AM
05:03AM
Mar-30-26 06:37PM
06:26PM
05:33PM
Mar-29-26 02:00PM
05:30AM
Mar-26-26 01:00PM
Mar-20-26 01:57PM
11:26AM
10:53AM
10:01AM
09:58AM
09:57AM
08:31AM
07:45AM
07:22AM
07:05AM
06:46AM
06:34AM
06:17AM
04:32AM
03:04AM
Mar-19-26 06:42PM
Mar-17-26 12:09PM
Mar-12-26 04:51PM
Mar-10-26 04:15PM
09:12AM
Mar-09-26 01:45PM
Feb-26-26 11:30AM
06:00AM
Feb-15-26 10:00PM
Feb-13-26 07:00PM
Feb-12-26 08:34AM
McCormick & Co., Inc. engages in the manufacturing, marketing, and distribution of spices, seasoning mixes, condiments, and other flavorful products to retail outlets, food manufacturers, and foodservice businesses. The firm offers the Aeroplane, Billy Bee, Cattlemen's BBQ Sauce, Cholula, Club House, Club House for Chefs, Drogheria & Alimentari, Ducros, El Guapo, FONA, Frank's RedHot, French's, and other related brands. It operates through the Consumer and Flavor Solutions segments. The Consumer segment sells spices, seasonings, condiments, and sauces. The Flavor Solutions segment includes seasoning blends, spices and herbs, condiments, coating systems, and compound flavors. The company was founded by Willoughby M. McCormick in 1889 and is headquartered in Baltimore, MD.
PresidentMr. Brendan M. Foley
Executive VP & CFOMr. Marcos Mendes Gabriel
VPMr. Jeffery D. Schwartz
Chief Human Relations OfficerMs. Sarah J. Piper
Chief Integration OfficerMr. Andrew Foust
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kurzius Lawrence Erik10% OwnerAug 10 '26Option Exercise49.02205,53810,076,500502,530Aug 12 10:46 AM
Kurzius Lawrence Erik10% OwnerAug 10 '26Sale52.69205,53810,829,201296,992Aug 12 10:46 AM
Conway Michael AaronDirectorJul 23 '26Buy50.211,10055,2271,100Jul 27 08:26 AM
Hattersley GavinDirectorApr 10 '26Buy52.982,000105,9602,906Apr 13 12:30 PM
Repas GregoryV.P. & ControllerMar 15 '26Option Exercise0.0055404,524Mar 17 11:50 AM
Gabriel Marcos MendesExecutive VP & CFOMar 15 '26Option Exercise0.00869013,723Mar 17 11:48 AM
Sanchez AnaPresident EMEAMar 15 '26Option Exercise0.0042708,737Mar 17 11:46 AM
Foust AndrewPresident, AmericasMar 15 '26Option Exercise0.00533013,461Mar 17 11:43 AM
Kurzius Lawrence Erik10% OwnerFeb 12 '26Option Exercise49.0250,0002,451,250346,992Feb 13 12:05 PM
Kurzius Lawrence Erik10% OwnerFeb 12 '26Sale71.6350,0003,581,500296,992Feb 13 12:05 PM
MANGAN MICHAEL DDirectorFeb 09 '26Option Exercise49.965,000249,80048,029Feb 10 02:10 PM
MANGAN MICHAEL DDirectorFeb 09 '26Sale67.925,000339,60043,029Feb 10 02:10 PM
MANGAN MICHAEL DDirectorFeb 05 '26Option Exercise49.965,000249,80046,780Feb 09 03:50 PM
Tapiero JacquesDirectorFeb 05 '26Option Exercise49.965,000249,80036,596Feb 09 03:41 PM
Tapiero JacquesDirectorFeb 05 '26Sale67.095,000335,45031,596Feb 09 03:41 PM
Schwartz Jeffery DVice President, Gen CounselFeb 03 '26Option Exercise49.9610,000499,600100,028Feb 05 01:20 PM
Tapiero JacquesDirectorFeb 03 '26Option Exercise49.965,000249,80036,596Feb 04 02:22 PM
Tapiero JacquesDirectorFeb 03 '26Sale63.855,000319,25031,596Feb 04 02:22 PM
Tapiero JacquesDirectorFeb 02 '26Option Exercise61.10634831,596Feb 03 12:30 PM
Kurzius Lawrence Erik10% OwnerJan 13 '26Option Exercise49.9650,0002,498,000296,762Jan 14 04:03 PM
Kurzius Lawrence Erik10% OwnerJan 13 '26Sale67.4350,0003,371,500246,762Jan 14 04:03 PM
Tapiero JacquesDirectorJan 02 '26Option Exercise67.2879253,31031,590Jan 06 03:53 PM
Brendan FoleyAffiliateNov 13 '25Proposed Sale65.5657,1443,746,361Nov 13 05:44 PM
Foley Brendan MChairman, President & CEONov 12 '25Option Exercise49.9657,1442,854,914165,796Nov 13 04:43 PM
Foley Brendan MChairman, President & CEONov 12 '25Sale65.5657,1443,746,361108,652Nov 13 04:43 PM
Kurzius Lawrence Erik10% OwnerNov 11 '25Sale64.5439,0142,517,9640Nov 12 12:13 PM
Kurzius Lawrence Erik10% OwnerOct 08 '25Option Exercise49.9650,0002,498,000296,762Oct 10 09:40 AM
Kurzius Lawrence Erik10% OwnerOct 08 '25Sale65.8650,0003,293,000246,762Oct 10 09:40 AM
Last Close
75.80
Aug 24 • 3:59 PM ET Dollar change-0.42 Percentage change(-0.55%)
Aftermarket Close
76.37
Aftermarket • 7:55 PM ET Dollar change+0.57 Percentage change(0.75%)
COO Cooper Companies Inc daily Stock Chart
Index
S&P 500
Market Cap
14.78B
Enterprise Value
17.10B
Income
235.80M
Sales
4.23B
Book/sh
42.27
Cash/sh
0.71
Employees
15000
IPO
Jan 21, 1983
P/E
64.02
Forward P/E
15.14
PEG
1.57
P/S
3.49
P/B
1.79
P/C
106.35
P/FCF
25.96
EV/EBITDA
14.82
EV/Sales
4.04
Quick Ratio
0.78
Current Ratio
1.27
Debt/Eq
0.30
LT Debt/Eq
0.23
Option/Short
Yes / Yes
EPS (ttm)
1.18
EPS next Y
5.01
EPS next Q
1.12
EPS this Y
12.41%
EPS next Y
8.10%
EPS next 5Y
9.64%
EPS past 3/5Y
-1.15% 9.30%
Sales past 3/5Y
7.35% 10.98%
EPS Y/Y TTM
-42.65%
Sales Y/Y TTM
6.09%
EPS Q/Q
-191.42%
Sales Q/Q
7.90%
Insider Own
0.60%
Insider Trans
0.00%
Inst Own
109.82%
Inst Trans
1.59%
ROA
1.89%
ROE
2.85%
ROIC
2.33%
Gross Margin
60.93%
Oper. Margin
18.19%
Profit Margin
5.57%
SMA20
1.08%
SMA50
5.28%
SMA200
3.29%
Trades
Shs Outstand
194.90M
Shs Float
193.85M
52W High
89.83 -15.62%
52W Low
58.89 28.71%
Volatility
1.65% 1.95%
ATR (14)
1.55
RSI (14)
58.32
Beta
0.83
Rel Volume
0.42
Avg Volume
2.71M
Volume
1,141,188
Perf Week
0.93%
Perf Month
7.81%
Perf Quarter
21.18%
Perf Half Y
-8.61%
Perf YTD
-7.52%
Perf Year
0.77%
Perf 3Y
-18.01%
Perf 5Y
-32.29%
Perf 10Y
63.87%
Prev Close
76.22
Price
75.80
Change %
-0.55%
Date Action Analyst Rating Change Price Target Change
Jul-28-26Initiated UBS Neutral $75
Jun-05-26Reiterated Needham Buy $101 → $86
Mar-04-26Downgrade Rothschild & Co Redburn Buy → Neutral $85
Feb-03-26Reiterated Needham Buy $100 → $99
Nov-13-25Downgrade Wells Fargo Overweight → Equal Weight $72
Oct-13-25Initiated Barclays Overweight $85
Oct-01-25Initiated Goldman Sell $64
Aug-28-25Downgrade Citigroup Buy → Neutral $72
Jul-22-25Upgrade BNP Paribas Exane Neutral → Outperform $92
Jun-17-25Upgrade Needham Hold → Buy $94
Jul-30-26 04:15PM
Jul-28-26 09:34AM
Jun-30-26 04:15PM
Jun-05-26 12:00PM
01:00AM
04:15PM Loading…
Jun-04-26 04:15PM
May-29-26 08:05AM
May-13-26 05:52PM
May-04-26 04:15PM
Apr-30-26 04:15PM
Apr-09-26 08:05AM
Mar-17-26 08:19AM
Mar-13-26 11:55AM
Mar-09-26 05:24PM
09:40AM
09:15AM Loading…
09:15AM
Mar-07-26 08:15AM
Mar-06-26 04:42PM
12:45PM
11:18AM
10:45AM
10:05AM
09:45AM
09:20AM
09:14AM
08:30AM
06:29AM
03:05AM
12:01AM
Mar-05-26 08:18PM
06:00PM Loading…
06:00PM
05:30PM
04:33PM
04:15PM
Mar-04-26 09:39AM
07:59AM
07:54AM
Mar-03-26 05:15PM
Mar-02-26 09:36AM
09:15AM
Feb-26-26 10:00AM
Feb-25-26 08:28AM
Feb-24-26 07:30PM
12:31PM
08:31AM
Feb-23-26 08:46AM
08:45AM
Feb-18-26 07:42AM
Feb-17-26 01:44PM
09:27AM
Feb-13-26 11:40AM
Feb-11-26 01:34PM
Feb-10-26 09:23AM
Feb-05-26 04:15PM
Feb-04-26 05:20PM
Feb-03-26 01:17PM
12:10PM
08:05AM
Feb-02-26 11:57AM
Jan-29-26 11:38PM
12:17PM
Jan-28-26 11:40AM
Jan-27-26 12:19PM
09:45AM
Jan-26-26 09:40AM
Jan-23-26 01:50PM
07:57AM
Jan-22-26 11:08AM
10:43AM
Jan-21-26 11:43AM
Jan-14-26 12:50PM
Jan-13-26 11:16AM
Jan-12-26 11:40AM
Jan-07-26 03:00PM
Jan-06-26 08:00AM
Jan-05-26 07:17AM
Jan-01-26 10:32PM
Dec-31-25 07:36AM
Dec-30-25 02:04PM
07:33AM
Dec-29-25 04:15PM
Dec-26-25 11:40AM
Dec-23-25 08:00AM
Dec-22-25 12:12PM
Dec-19-25 09:55AM
Dec-16-25 11:05PM
11:37AM
Dec-12-25 09:50AM
Dec-11-25 07:34AM
12:31AM
Dec-10-25 11:40AM
Dec-08-25 09:40AM
09:15AM
Dec-05-25 11:11AM
11:02AM
09:11AM
07:36AM
02:46AM
12:31AM
12:02AM
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
PresidentMr. Albert G. White III
Executive VPMr. Daniel G. McBride Esq.
President of CooperSurgicalMs. Holly R. Sheffield
President of CooperVisionMr. Gerard H. Warner III
Vice President of Investor Relations & Risk ManagementMr. Kim Duncan
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rosebrough Walter M JrDirectorApr 01 '26Option Exercise0.008320832Apr 21 05:45 PM
WEISS ROBERT SDirectorApr 01 '26Option Exercise0.003,6540292,599Apr 06 05:16 PM
Rivas MariaDirectorApr 01 '26Option Exercise0.003,32203,322Apr 06 05:16 PM
Jay ColleenDirectorApr 01 '26Option Exercise0.003,322039,907Apr 06 05:16 PM
Carbone BarbaraDirectorApr 01 '26Option Exercise0.003,05003,050Apr 06 05:15 PM
MADDEN TERESA SDirectorApr 01 '26Option Exercise0.003,322015,679Apr 06 05:15 PM
Lucchese Cynthia LDirectorApr 01 '26Option Exercise0.003,322012,767Apr 06 05:14 PM
Kurzius Lawrence ErikDirectorApr 01 '26Option Exercise0.003,322011,099Apr 06 05:14 PM
Jay ColleenDirectorJan 12 '26Option Exercise39.407,064278,32236,585Jan 14 04:05 PM
White Albert G IIIPresident & CEOJan 08 '26Option Exercise0.0018,3400254,491Jan 12 04:24 PM
Warner Gerard H IIIPresident, CooperVision, Inc.Jan 08 '26Option Exercise0.0011,518029,837Jan 12 04:24 PM
Sheffield Holly RPresident, CSIJan 08 '26Option Exercise0.008,050047,102Jan 12 04:23 PM
McBride Daniel GEVP & Chief Operating OfficerJan 08 '26Option Exercise0.0012,887076,007Jan 12 04:23 PM
Andrews Brian GEVP, CFO & TreasurerJan 08 '26Option Exercise0.003,528010,430Jan 12 04:22 PM
Lucchese Cynthia LDirectorDec 22 '25Buy84.061,784149,9639,445Dec 23 04:08 PM
Rivas MariaDirectorDec 18 '25Buy82.131,00082,13011,141Dec 19 04:18 PM
Kurzius Lawrence ErikDirectorDec 17 '25Buy82.502,000165,0007,777Dec 17 05:06 PM
Sheffield Holly RPresident, CSIDec 16 '25Buy80.751,23099,32239,052Dec 16 06:36 PM
White Albert G IIIPresident & CEODec 16 '25Buy80.8010,000808,000236,151Dec 16 06:36 PM
Kurzius Lawrence ErikDirectorSep 29 '25Buy68.392,000136,7805,777Sep 29 08:36 PM
White Albert G IIIPresident & CEOSep 05 '25Buy68.3910,000683,900226,151Sep 05 05:10 PM
Warner Gerard H IIIPresident, CooperVision, Inc.Sep 05 '25Buy69.231,450100,38418,319Sep 05 04:07 PM
McBride Daniel GEVP & Chief Operating OfficerSep 02 '25Buy65.043,000195,12063,120Sep 02 05:17 PM
Andrews Brian GEVP, CFO & TreasurerSep 02 '25Buy65.681,525100,16222,191Sep 02 05:16 PM